Orient Pharma Co Ltd (ROCO:4166)
NT$ 26.6 -0.3 (-1.12%) Market Cap: 5.93 Bil Enterprise Value: 6.41 Bil PE Ratio: 50.28 PB Ratio: 3.34 GF Score: 65/100

Orient Pharma Co Ltd (ROCO:4166) Transcripts

    • 1